Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821242) titled 'Nimotuzumab Plus Radiotherapy in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma' on Sept. 3.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ke Hu
Condition:
Head & Neck Cancer
Radiotherapy
Intervention:
Drug: Nimotuzumab
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: September 10, 2026
Target Sample Size: 46
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07821242
Disclaimer:...